NAVB - Navidea Biophar Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 SPY (-0.13%) POLA (4.94%) OCGN (2.03%) MOXC (21.98%) MGNI (3.88%) GSAT (-4.84%) GRWG (4.3%) GOED (11.97%) GME (0%) FURY (0%) ETSY (0%) ENG (0%) CWH (0%) CRSR (0%) CPE (0%) CELH (0%) BZUN (0%) BFLY (-2.62%) BBIG (0%) BA (-0.09%) AVXL (0%) AU (0%) AMPUSD (%) AMC (0.06%) ABNB (1.27%)

NAVB - Navidea Biopharmaceu...

$1.91 0[0%]

15 mins delayed data

People also watch :

+Watchlist

2 StockHoot Traders following this.
Analyst Ratings | Earnings

Previous Close	$1.91	Open
Volume	838	Market Cap	51.96M
Yield		Last Dividend

Day

52 Week

Macrophage Therapeutics, Inc. Wins Delaw...	6:00 AM
DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (Navidea or the Company), a company focused on the development o...

This Stocks might change the Kismet of I...	06/23/21
The Shyft Group, Inc. (SHYF) with the stream of -1.41% also noticed, India Navidea Biopharmaceuticals, Inc. (NAVB) encountered a rapid change of 3.35%...

Investors are Unsure How to React (Brief...	06/20/21
On Friday, Shares of Navidea Biopharmaceuticals, Inc. (AMEX:NAVB) reached at $1.96 price level during last trade its distance from 20 days simple movi...

Hesitation to buy this Stock might leave...	06/17/21
IVERIC bio, Inc. (ISEE) with the stream of -2.35% also noticed, India Navidea Biopharmaceuticals, Inc. (NAVB) encountered a rapid change of 2.56% in t...

Signals from Technical Perspective- Navi...	06/15/21
On Tuesday, Shares of Navidea Biopharmaceuticals, Inc. (AMEX:NAVB) reached at $2.00 price level during last trade its distance from 20 days simple mov...

Here is What Hedge Funds Think About Nav...	06/14/21
No summary available.

Navidea receives patent for dextran-base...	05/19/21
Navidea Biopharmaceuticals (NYSE:NAVB) announced today that it received a patent for its dextran-based drug delivery vehicles. The U.S. Patent and Tra...

Navidea issued U.S. patent for diagnosis...	05/19/21
No summary available.

Navidea Biopharmaceuticals Announces Iss...	05/18/21
Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (Navidea or the Company), a company focused on the development of precision immunodiagnostic ag...

Navidea Biopharmaceuticals, Inc. (NAVB) ...	05/11/21
No summary available.

Navidea Biopharm EPS misses by $0.03, mi...	05/11/21
No summary available.

Navidea: Q1 Earnings Snapshot	05/11/21
DUBLIN, Ohio (AP) _ Navidea Biopharmaceuticals Inc. (NAVB) on Tuesday reported a loss of $3 million in its first quarter. The Dublin, Ohio-based compa...

Buy, Sell or Hold? before and after EPS ...	05/11/21
Earnings results for Navidea Biopharmaceuticals , Analyst Opinion on Navidea Biopharmaceuticals , Earnings and Valuation of (NYSEAMERICAN:NAVB), Stock...

Navidea Bio reports NIH grant to evaluat...	05/11/21
No summary available.

Navidea Biopharmaceuticals Announces NIH...	05/10/21
Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (Navidea or the Company), a company focused on the development of precision immunodiagnostic ag...

ANALYST RATINGS

0 analyst ratings (Last 3 months)

0.00 %

Strong Buy + Buy

Price Target (PT)

EARNINGS

Date	04/12/2019 (AMC)	Est. (EPS/Rev.)	$1.37
Actual (EPS/Rev.)	$2.5B	EPS (TTM)	$???

TRADERS TRACKING $NAVB

Service Name	Trader	% Success
FEAT. ANDRE 3000	JOHN KROLIKOWSKI JR	84.00 %	Follow
Pennies	Mmkt0652	84.00 %	Follow

SHOW ALL TRADERS

About Us

Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.

Product Types

Strategies

Follow Us

Secure Payments

We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.